• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在日本食管鳞状细胞癌患者中,用奈达铂替代顺铂进行以5-氟尿嘧啶/顺铂为基础的根治性放化疗。

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.

作者信息

Kuwahara Akiko, Yamamori Motohiro, Nishiguchi Kohshi, Okuno Tatsuya, Chayahara Naoko, Miki Ikuya, Tamura Takao, Inokuma Tsubasa, Takemoto Yoshiji, Nakamura Tsutomu, Kataoka Kazusaburo, Sakaeda Toshiyuki

机构信息

School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan.

出版信息

Int J Med Sci. 2009 Sep 28;6(6):305-11. doi: 10.7150/ijms.6.305.

DOI:10.7150/ijms.6.305
PMID:19834547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2757668/
Abstract

OBJECTIVE

The effects of replacing cisplatin (CDDP) with cis-diammineglycolatoplatinum (nedaplatin, NDP), a second-generation platinum complex, on the pharmacokinetics of 5-fluorouracil (5-FU) were investigated in Japanese patients with esophageal squamous cell carcinoma, who were treated with a definitive 5-FU/CDDP-based chemoradiotherapy.

METHODS

Fifty-six patients were enrolled, 49 treated with CDDP and 7 treated with NDP. A course consisted of continuous infusion of 5-FU at 400 mg/m(2)/day for days 1-5 and 8-12, infusion of CDDP or NDP at 40 mg/m(2)/day on days 1 and 8, and radiation at 2 Gy/day on days 1 to 5, 8 to 12, and 15 to 19, with a second course repeated after a 2-week interval. Plasma concentrations of 5-FU were determined by high performance liquid chromatography at 5 PM on days 3, 10, 38 and 45, and at 5 AM on days 4, 11, 39 and 46.

RESULTS AND CONCLUSIONS

The circadian rhythm in plasma concentrations of 5-FU observed in the case of CDDP was altered when NDP was used instead. The clinical response can be predicted by monitoring plasma concentrations of 5-FU in the CDDP group, but not in the NDP group.

摘要

目的

在接受以5-氟尿嘧啶(5-FU)和顺铂(CDDP)为主的根治性放化疗的日本食管鳞状细胞癌患者中,研究用第二代铂类复合物顺二氨环丁烷羧酸铂(奈达铂,NDP)替代顺铂(CDDP)对5-氟尿嘧啶(5-FU)药代动力学的影响。

方法

招募了56例患者,其中49例接受CDDP治疗,7例接受NDP治疗。一个疗程包括在第1至5天和第8至12天以400mg/m²/天的剂量持续输注5-FU,在第1天和第8天以40mg/m²/天的剂量输注CDDP或NDP,以及在第1至5天、第8至12天和第15至19天以2Gy/天的剂量进行放疗,间隔2周后重复第二个疗程。在第3、10、38和45天下午5点以及第4、11、39和46天上午5点通过高效液相色谱法测定5-FU的血浆浓度。

结果与结论

当使用NDP替代CDDP时,观察到的5-FU血浆浓度的昼夜节律发生了改变。在CDDP组中,通过监测5-FU的血浆浓度可以预测临床反应,但在NDP组中则不行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434d/2757668/b5794baab198/ijmsv06p0305g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434d/2757668/c9342c7a264b/ijmsv06p0305g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434d/2757668/b5794baab198/ijmsv06p0305g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434d/2757668/c9342c7a264b/ijmsv06p0305g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/434d/2757668/b5794baab198/ijmsv06p0305g02.jpg

相似文献

1
Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.在日本食管鳞状细胞癌患者中,用奈达铂替代顺铂进行以5-氟尿嘧啶/顺铂为基础的根治性放化疗。
Int J Med Sci. 2009 Sep 28;6(6):305-11. doi: 10.7150/ijms.6.305.
2
Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.顺式二氨甘醇酸铂(奈达铂)联合5-氟尿嘧啶与顺铂联合5-氟尿嘧啶方案治疗日本II-IV期食管癌的回顾性研究
Dis Esophagus. 2006;19(1):15-9. doi: 10.1111/j.1442-2050.2006.00531.x.
3
Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma.剂量递增 5-氟尿嘧啶对 III/IVa 期食管鳞癌日本患者其药代动力学昼夜变化的影响。
Int J Med Sci. 2010 Jan 31;7(1):48-54. doi: 10.7150/ijms.7.48.
4
Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.日本食管鳞癌患者接受以氟尿嘧啶和顺铂为基础的放化疗后,血浆中氟尿嘧啶浓度对长期生存的影响。
J Exp Clin Cancer Res. 2011 Oct 5;30(1):94. doi: 10.1186/1756-9966-30-94.
5
VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.VEGF-634C/G 基因型可预测日本食管鳞癌患者接受以氟尿嘧啶/顺铂为基础的放化疗后的长期生存。
Int J Med Sci. 2012;9(10):833-7. doi: 10.7150/ijms.4914. Epub 2012 Nov 1.
6
TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.TNFRSF1B A1466G 基因型可预测日本食管鳞癌患者接受以氟尿嘧啶/顺铂为基础的标准放化疗后的临床疗效。
J Exp Clin Cancer Res. 2010 Jul 20;29(1):100. doi: 10.1186/1756-9966-29-100.
7
[Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].奈达铂与5-氟尿嘧啶同步放化疗治疗局部晚期食管鳞状细胞癌
Gan To Kagaku Ryoho. 2009 Nov;36(12):1997-9.
8
Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.基于门诊治疗的奈达铂联合替吉奥每月给药方案在早期、进展期和复发食管癌根治性或挽救性同步放化疗中的疗效及可行性
Radiat Oncol. 2016 Jan 19;11:4. doi: 10.1186/s13014-016-0587-9.
9
Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma.奈达铂联合三维适形放疗治疗局部晚期食管癌。
World J Gastroenterol. 2013 Dec 28;19(48):9447-52. doi: 10.3748/wjg.v19.i48.9447.
10
[A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].[1例晚期食管癌伴多发淋巴结转移患者经奈达铂和5-氟尿嘧啶诱导化疗后行放化疗成功治疗]
Gan To Kagaku Ryoho. 2002 Aug;29(8):1417-20.

引用本文的文献

1
What is the Reason That the Pharmacological Future of Chemotherapeutics in the Treatment of Lung Cancer Could Be Most Closely Related to Nanostructures? Platinum Drugs in Therapy of Non-Small and Small Cell Lung Cancer and Their Unexpected, Possible Interactions. The Review.为什么化疗药物在肺癌治疗中的药理前景可能与纳米结构最密切相关?铂类药物在非小细胞肺癌和小细胞肺癌治疗中的作用及其意想不到的可能相互作用。综述。
Int J Nanomedicine. 2024 Sep 14;19:9503-9547. doi: 10.2147/IJN.S469217. eCollection 2024.
2
Emerging role of non-coding RNAs in resistance to platinum-based anti-cancer agents in lung cancer.非编码RNA在肺癌对铂类抗癌药物耐药中的新作用
Front Pharmacol. 2023 Jan 26;14:1105484. doi: 10.3389/fphar.2023.1105484. eCollection 2023.
3

本文引用的文献

1
Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.食管癌放化疗中的药代动力学与药物基因组学
Adv Drug Deliv Rev. 2009 May 20;61(5):388-401. doi: 10.1016/j.addr.2008.10.005. Epub 2008 Dec 24.
2
Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.通过计算建模确定抗癌药物5-氟尿嘧啶和奥沙利铂的时辰耐受性和时辰疗效机制。
Eur J Pharm Sci. 2009 Jan 31;36(1):20-38. doi: 10.1016/j.ejps.2008.10.024. Epub 2008 Nov 11.
3
VEGF G-1154A is predictive of severe acute toxicities during chemoradiotherapy for esophageal squamous cell carcinoma in Japanese patients.
Metallo-Drugs in Cancer Therapy: Past, Present and Future.金属药物在癌症治疗中的应用:过去、现在和未来。
Molecules. 2022 Oct 1;27(19):6485. doi: 10.3390/molecules27196485.
4
Recent Advances in the Development of Noble Metal NPs for Cancer Therapy.用于癌症治疗的贵金属纳米颗粒开发的最新进展
Bioinorg Chem Appl. 2022 Jan 28;2022:2444516. doi: 10.1155/2022/2444516. eCollection 2022.
5
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents.五种铂类抗肿瘤药物的耐药机制
Front Pharmacol. 2020 Mar 20;11:343. doi: 10.3389/fphar.2020.00343. eCollection 2020.
6
Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.使用日本药品不良事件报告数据库分析铂类化合物相关的肾功能损害不良事件。
SAGE Open Med. 2018 Apr 27;6:2050312118772475. doi: 10.1177/2050312118772475. eCollection 2018.
7
Nedaplatin enhanced apoptotic effects of ABT-737 in human cancer cells via Mcl-1 inhibition.奈达铂通过抑制Mcl-1增强ABT-737对人癌细胞的凋亡作用。
Oncol Lett. 2016 Nov;12(5):4195-4202. doi: 10.3892/ol.2016.5151. Epub 2016 Sep 20.
8
Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.基因组分析显示,FAM84B和NOTCH信号通路与食管鳞状细胞癌的进展相关。
Gigascience. 2016 Jan 11;5:1. doi: 10.1186/s13742-015-0107-0. eCollection 2016.
9
Nanocarriers for delivery of platinum anticancer drugs.纳米载体用于递送铂类抗癌药物。
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1667-85. doi: 10.1016/j.addr.2013.09.014. Epub 2013 Oct 8.
10
Therapeutic and radiosensitizing effects of armillaridin on human esophageal cancer cells.阿魏菇素对人食管癌细胞的治疗和放射增敏作用。
Evid Based Complement Alternat Med. 2013;2013:459271. doi: 10.1155/2013/459271. Epub 2013 Jun 24.
VEGF基因G-1154A多态性可预测日本食管癌患者放化疗期间的严重急性毒性反应。
Ther Drug Monit. 2008 Aug;30(4):497-503. doi: 10.1097/FTD.0b013e318180e3d2.
4
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.生物钟对癌症治疗药物节律性给药的影响。
Adv Drug Deliv Rev. 2007 Aug 31;59(9-10):1015-35. doi: 10.1016/j.addr.2006.11.001. Epub 2007 Jul 4.
5
Favorable genetic polymorphisms predictive of clinical outcome of chemoradiotherapy for stage II/III esophageal squamous cell carcinoma in Japanese.预测日本II/III期食管鳞状细胞癌放化疗临床结局的有利基因多态性
Am J Clin Oncol. 2007 Jun;30(3):252-7. doi: 10.1097/01.coc.0000256059.88247.25.
6
Highlights from: 5-Fluorouracil Drug Management Pharmacokinetics and Pharmacogenomics Workshop; Orlando, Florida; January 2007.亮点来自:5-氟尿嘧啶药物管理、药代动力学和药物基因组学研讨会;佛罗里达州奥兰多;2007年1月。
Clin Colorectal Cancer. 2007 Mar;6(6):407-22. doi: 10.1016/s1533-0028(11)70480-7.
7
Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma.食管鳞状细胞癌根治性放化疗后完全缓解病例的晚期毒性反应
J Gastroenterol. 2006 May;41(5):425-32. doi: 10.1007/s00535-006-1771-8.
8
Evaluation of combined nedaplatin and docetaxel therapy for human head and neck cancer in vivo.
Anticancer Res. 2006 Mar-Apr;26(2A):989-94.
9
Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.顺式二氨甘醇酸铂(奈达铂)联合5-氟尿嘧啶与顺铂联合5-氟尿嘧啶方案治疗日本II-IV期食管癌的回顾性研究
Dis Esophagus. 2006;19(1):15-9. doi: 10.1111/j.1442-2050.2006.00531.x.
10
Circadian rhythm in dihydropyrimidine dehydrogenase activity and reduced glutathione content in peripheral blood of nasopharyngeal carcinoma patients.鼻咽癌患者外周血中二氢嘧啶脱氢酶活性和还原型谷胱甘肽含量的昼夜节律
Chronobiol Int. 2005;22(4):741-54. doi: 10.1080/07420520500179969.